Current approaches to the diagnosis, treatment, and reporting of trichomoniasis and candidosis.
The current approach to the management of trichomoniasis and candidosis in sexually transmitted disease (STD) clinics in England and Wales is described. Microscopy alone was used in the diagnosis of trichomoniasis in 44% of clinics and of candidosis in 35% of clinics. Oral metronidazole was used for the treatment of trichomoniasis in women in 92% of clinics. Vaginal pessaries containing nystatin or clotrimazole were routinely used to treat candidosis in 95% of clinics. Male sexual contacts of female patients with candidosis and trichomoniasis were invited to attend for examination in 88% of clinics. Physicians in 81% of clinics prescribed treatment on epidemiological grounds for male contacts of female patients with trichomoniasis. A more uniform approach to the diagnostic categories used for the quarterly returns for cases treated epidemiologically is recommended.
D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission; D003022:Clotrimazole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008499:Medical Records / Q000592:standards; D008795:Metronidazole / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D014247:Trichomonas Vaginitis / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission
D009761:Nystatin; D008795:Metronidazole; D003022:Clotrimazole